New pill aims to stop Surgically-Removed lung cancer in its tracks
NCT ID NCT07154706
Summary
This study is testing whether a drug called taletrectinib can prevent early-stage lung cancer from returning after surgery. It will compare the drug to a placebo (sugar pill) in about 180 patients whose cancer has a specific genetic feature called ROS1-fusion. The main goal is to see if patients taking the drug stay cancer-free longer than those taking the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Georgetown University Medical Cener (GUMC)
RECRUITINGWashington D.C., District of Columbia, 20007, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
MD Anderson
RECRUITINGHouston, Texas, 45559, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Princess Margaret Cancer Centre-University Health Network
RECRUITINGToronto, Ontario, MG5 1Z5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Saint Alphonsus Health System
RECRUITINGBoise, Idaho, 83706, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sarah Cannon Research Institute (SCRI) - Texas Oncology-Central South
RECRUITINGAustin, Texas, 78731, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UCLA
RECRUITINGLos Angeles, California, 90404, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Virginia Cancer Specialists
RECRUITINGFairfax, Virginia, 22031, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.